Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Epoprostenol
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2Epoprostenol FOR injection
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3Epoprostenol sodico
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4Epoprostenol sodium
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5Epoprostenol-actelion
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6NEW thermo stable formulation OF epoprostenol sodium
(D00106)		1件: Epoprostenol2件: Epoprostenol (D00106),
Epoprostenol sodium 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬